Skip to content

Effects of thoracic regional anegesia on postoperative atrial fibrilation for minimally invasive cardiac surgery

Effects of thoracic regional anegesia on postoperative new-onset atrial fibrilation for minimally invasive cardiac surgery

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000041350
Enrollment
Unknown
Registered
2020-12-24
Start date
2021-01-05
Completion date
Unknown
Last updated
2021-03-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Adult heart disease

Interventions

GA:Inhalation and intravenous general anesthesia
SPB:serratus anterior plane block
PVB:Thoracic paravertebral block

Sponsors

Tianjin Chest Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Patients younger than 65 years old are male or female; 2. Patients with preoperative sinus heart rate meeting the surgical indications include coronary heart disease, patent ductus arteriosus, atrial and ventricular septal defects, moderate and severe mitral, tricuspid and aortic stenosis or insufficiency, benign cardiac tumors, etc.; 3. Patients who plan to undergo intercostal off-pump coronary artery bypass grafting or minimally invasive cardiopulmonary bypass through right or left atrium.

Exclusion criteria

Exclusion criteria: 1. Severe obesity (BMI > 32); 2. Patients with severe thoracic deformity, such as pectus excavatum, whose heart is completely located in the left chest, can not provide the best surgical exposure; 3. Patients with severe adhesion of thoracic cavity through approach; 4. Patients with severe vascular diseases, including abdominal aorta, iliac artery or femoral artery disease, or severe aortic atherosclerosis, ascending aorta diameter greater than 40mm, aortic coarctation, and arterial duct calcification; 5. Patients with NYHA grade IV, low cardiac output syndrome, liver and kidney dysfunction, and recent neurological signs such as embolism; 6. Patients with congenital shunt heart disease complicated with severe pulmonary hypertension, bi-directional shunt or - 13 cyanosis, or complicated with other severe intracardiac malformations; 7. Patients with common femoral artery stenosis > 50%; 8. Patients with common femoral artery hematoma, pseudoaneurysm and arteriovenous fistula; 9. Patients with severe calcification of common femoral artery wall; 10. Patients with common femoral artery diameter less than 7 mm; 11. Patients whose puncture site is artificial blood vessel or great saphenous vein bypass; 12. Patients with severe coagulation dysfunction; 13. Patients with skin infection around the puncture point.

Design outcomes

Primary

MeasureTime frame
perioperative new-onset atrial fibrilation;

Secondary

MeasureTime frame
Time of onset of nerve block;Nerve block range;postoperative visual analog pain scores;Opioid use doses;Chronic pain 2 months after operation;arterial blood gas analysis;

Countries

China

Contacts

Public ContactEr Jianxu

Tianjin Chest Hospital

erjianxuwow@126.com+86 13512265267

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 14, 2026